Check out your Company Bowl for anonymous work chats.
2023 will be a big year for us here at Novartis. We are working towards achieving gender balance in management by 2023, because we believe a balanced world is a better world. http://glassdoor.com/slink.htm?key=vMCsu
We are working to transform our industry and the lives of millions through digital and data innovation. Join the journey to reimagine medicine: http://glassdoor.com/slink.htm?key=vQomd
One job. Two associates: ’Our job share enables us to be successful together, while giving us more time with our families.’ Hear Robert and Stefan’s story. http://glassdoor.com/slink.htm?key=vQ32M
We have a history of firsts, and there’s more to come. Join us in 2019 and be a part of the journey. http://glassdoor.com/slink.htm?key=vQOmr
Fix ‘one’ thing! Novartis is moving to an ‘unbossed’ employee culture, CEO Vas Narasimhan and best-selling author Dan Pink talk about how small steps can make a big difference. http://glassdoor.com/slink.htm?key=vQO5V http://glassdoor.com/slink.htm?key=vQO5z
'Novartis allowed me to adapt my work schedule to fit my family needs.’ Ana shares her flexible working experience at Novartis. http://glassdoor.com/slink.htm?key=vQJtj
‘Novartis allowed me to adapt my work schedule to fit my family needs.’ Ana shares her flexible working experience at Novartis.
With over 23,000 scientists, physicians and business professionals dedicated to research and development we are proud to be a 2018 Science Top Employer. Thank you to our colleague Maria for sharing her words.
Today is International Coming Out Day. For us, it’s our differences that make us innovative and powerful. This is why we fully support the @UNHumanRights global #LGBTI business standards. Click to find out more about the standards: http://glassdoor.com/slink.htm?key=vQxEk
'The world is diverse, and we need to reflect that. Eliminating bias is critical to building a company which more truly reflects the patient community we serve' Paul Adang, our Head of Talent Acquisition. Review the Novartis approach here: http://glassdoor.com/slink.htm?key=vQkJE
